IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma.
Kuijjer ML, Peterse EF, van den Akker BE, Briaire-de Bruijn IH, Serra M, Meza-Zepeda LA, Myklebost O, Hassan AB, Hogendoorn PC, Cleton-Jansen AM.
Kuijjer ML, et al. Among authors: hogendoorn pc.
BMC Cancer. 2013 May 20;13:245. doi: 10.1186/1471-2407-13-245.
BMC Cancer. 2013.
PMID: 23688189
Free PMC article.